| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/30/2009 | CN100574770C Slow releasing micro pill preparation of loosestrife extract and its preparation process |
| 12/30/2009 | CN100574767C Composition for preventing mammmal vagina infection and use |
| 12/30/2009 | CN100574765C A medicine for treating hyperphosphatemia disease and iron deficiency anemia disease |
| 12/30/2009 | CN100574763C Topically stabilized prostaglandin E compound dosage forms |
| 12/30/2009 | CN100574761C Mycophenolate mofetil dry suspension agent |
| 12/30/2009 | CN100574759C Method for preparing lansoprazole intestine dissolving capsule |
| 12/30/2009 | CN100574757C Acetylcysteine or its salt and anti-infectious medicine composition |
| 12/30/2009 | CN100574755C Hot melt transcutaneous therapeutic system for administering D2 accelerator |
| 12/30/2009 | CN100574753C Medicinal salt with local narcosis and antiphlogosis activity and its preparation process |
| 12/30/2009 | CN100574751C Tiotropium containing powder formulation for inhalation |
| 12/30/2009 | CN100574750C Rapidly-disintegrating formulation for releasing active ingredients |
| 12/30/2009 | CN100574749C Enrobed core |
| 12/30/2009 | CN100574748C Releasing control piece of time-selecting releasing osmotic pump |
| 12/30/2009 | CN100574747C Pediatric paracetamol gelatin preparation for children and its preparing method |
| 12/30/2009 | CA2765298A1 Probiotic bacterial molecules and their use in methods to treat/prvent infection by harmful bacteria and to provide nutritional health |
| 12/30/2009 | CA2731853A1 Compacted polyallylamine polymer |
| 12/30/2009 | CA2729139A1 Octreotide implant having a release agent |
| 12/30/2009 | CA2729093A1 Agent for regenerating tympanic membrane or external auditory canal |
| 12/30/2009 | CA2729015A1 Coated particles containing pharmaceutically active agents |
| 12/30/2009 | CA2728960A1 Polymer-metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 12/30/2009 | CA2728952A1 Percutaneous absorption enhancer and transdermal preparation using the same |
| 12/30/2009 | CA2728852A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
| 12/30/2009 | CA2728727A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
| 12/30/2009 | CA2728539A1 Pharmaceutical compositions of rosuvastatin calcium |
| 12/30/2009 | CA2728502A1 Liquid composition of cisplatin coordination compound |
| 12/30/2009 | CA2728456A1 Acetic acid and a buffer |
| 12/30/2009 | CA2728391A1 Composition and method for enhancing fluoride uptake using bioactive glass |
| 12/30/2009 | CA2728358A1 Storage-stable, functionally intact fibrinogen |
| 12/30/2009 | CA2727726A1 Transdermal delivery apparatus and method |
| 12/30/2009 | CA2726836A1 Dermal delivery |
| 12/30/2009 | CA2726283A1 Stimulation of cartilage formation using reduced pressure treatment |
| 12/30/2009 | CA2726136A1 Stabilized transdermal drug delivery system |
| 12/30/2009 | CA2723313A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 12/29/2009 | US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery |
| 12/29/2009 | US7638556 Freeze-dried product of N-[o-(p-pivaloyloxy benzenesulfonylamino)benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof |
| 12/29/2009 | US7638545 Anthelmintic composition |
| 12/29/2009 | US7638524 For reducing serum cholesterol in a mammal |
| 12/29/2009 | US7638506 cationic surfactants; wear resistance; kneading, extrusion; sustained release |
| 12/29/2009 | US7638494 G-type peptides to ameliorate atherosclerosis |
| 12/29/2009 | US7638335 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 12/29/2009 | US7638145 Cutting tree; aeration; purification |
| 12/29/2009 | US7638143 Fluidized bed granulation, compression to form tablets |
| 12/29/2009 | US7638140 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 12/29/2009 | US7638139 Heat source kills cells without protein denaturization; liposomes; age related macular degeneration |
| 12/29/2009 | US7638138 Compositions for nasal administration of pharmaceuticals |
| 12/29/2009 | US7638137 Ophthalmic drug delivery system |
| 12/29/2009 | US7638115 Methods and compositions for the introduction of molecules into cells |
| 12/29/2009 | US7638114 antimicrobial formulation free from ethanol and isopropanol and comprises propylene glycol and tannic acid, is distributed or atomized to the air to reduce the concentration of germs |
| 12/29/2009 | US7638092 Artificial lipid bilayer membrane lipid substitution method, artificial lipid bilayer membrane obtained by using lipid substitution method, artificial lipid bilayer membrane formation device and ion permeation measuring device |
| 12/29/2009 | US7638081 Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent |
| 12/29/2009 | US7637891 Method and device for painless injection of medication |
| 12/29/2009 | CA2484164C Androgen pharmaceutical composition and method for treating depression |
| 12/29/2009 | CA2468703C Controlled release polymeric compositions of bone growth promoting compounds |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2447521C Delivery of antihistamines through an inhalation route |
| 12/29/2009 | CA2446798C Solid pharmaceutical compositions comprising cyclosporin |
| 12/29/2009 | CA2422871C Stable solid dosage forms of amino acids and processes for producing same |
| 12/29/2009 | CA2412575C Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| 12/29/2009 | CA2384624C Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 12/29/2009 | CA2335663C Cosmetic and pharmaceutical oil-in-water emulsions |
| 12/29/2009 | CA2316750C Oligomer for media to entrap microorganism, oligomer-polymerized hydrous gel, and oligomer-polymerized hydrous gel entrapping microorganism |
| 12/29/2009 | CA2304948C Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 12/29/2009 | CA2291087C Compositions suitable for controlled release of the hormone gnrh and its analogs |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090318934 Compressible/expandable medical graft products, and methods for applying hemostasis |
| 12/24/2009 | US20090318665 Pharmaceutical formulations |
| 12/24/2009 | US20090318398 Androgen pharmaceutical composition and method for treating depression |
| 12/24/2009 | US20090318397 Combination of Azelastine and Steroids |
| 12/24/2009 | US20090318383 Compositions and methods for modulation of vascular structure and/or function |
| 12/24/2009 | US20090317908 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 12/24/2009 | US20090317485 Skin Protectant Spray Compositions |
| 12/24/2009 | US20090317481 Modafinil formulations |
| 12/24/2009 | US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii |
| 12/24/2009 | US20090317479 Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
| 12/24/2009 | US20090317478 Method of preparing covered porous biodegradable polymer microspheres for sustained-release drug delivery and tissue regeneration |
| 12/24/2009 | US20090317477 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
| 12/24/2009 | US20090317476 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
| 12/24/2009 | US20090317475 Combination antitumor therapies |
| 12/24/2009 | US20090317474 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing |
| 12/24/2009 | US20090317473 Controlled-release formulations, method of manufacture, and use thereof |
| 12/24/2009 | US20090317472 Controlled releases of actives in skin |
| 12/24/2009 | US20090317471 matrix contains drug (hypotensive agents, antidepressants, anticonvulsants), ionic non-gelling matrix polymer (cellulose acetetate phthalate), and pH modifier; free of gelling or swelling excipient |
| 12/24/2009 | US20090317470 Oramucosal Pharmaceutical Dosage Form |
| 12/24/2009 | US20090317469 Composite extracellular matrix materials and medical products formed therefrom |
| 12/24/2009 | US20090317468 Multicompartment granulate formulations for active substances |
| 12/24/2009 | US20090317467 Hydrocolloid composition |
| 12/24/2009 | US20090317466 Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine |
| 12/24/2009 | US20090317465 Composition and method of preparation of release systems for constant (zero-order) release of active agents |
| 12/24/2009 | US20090317464 Methods and compositions for producing anti-androgenic effects |
| 12/24/2009 | US20090317463 Composition for oral use based on s-adenosylmethionine and a process for their preparation |
| 12/24/2009 | US20090317462 Peptide pharmaceutical for oral delivery |
| 12/24/2009 | US20090317461 Oral compositions effective for the treatment of oral cavity malodor associated with the consumption of odor-causing compounds |
| 12/24/2009 | US20090317460 Solid dosage form |
| 12/24/2009 | US20090317459 Material |
| 12/24/2009 | US20090317458 Fluid-jet pens configured for making modulated release bioactive agents |
| 12/24/2009 | US20090317457 Anti-inflammatory and wound healing effects of lymphoid thymosin b-4 |
| 12/24/2009 | US20090317456 Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer |
| 12/24/2009 | US20090317455 Reverse targeting lipid vesicle |
| 12/24/2009 | US20090317454 Body or plant part dressing |
| 12/24/2009 | US20090317453 Transdermal and topical administration of drugs using basic permeation enhancers |